Aarti Pharmalabs announced that the Board of Directors of the Company at its meeting held on 9 February 2026, inter alia, have recommended the interim dividend of Rs 1.5 per equity Share (i.e. 30%) , subject to the approval of the shareholders.Powered by Capital Market - Live News

Net profit of Aarti Pharmalabs declined 35.18% to Rs 47.96 crore in the quarter ended December 2025 as against Rs 73.99 crore during the previous quarter ended December 2024. Sales declined 19.62% to Rs 432.27 crore in the quarter ended December 2025 as against Rs 537.78 crore during the previous quarter ended December 2024. ParticularsQuarter EndedDec. 2025Dec. 2024% Var. Sales432.27537.78 -20 OPM %23.6723.91 - PBDT94.28123.66 -24 PBT65.66100.63 -35 NP47.9673.99 -35 Powered by Capital Market - Live News

Aarti Pharmalabs will hold a meeting of the Board of Directors of the Company on 9 February 2026.Powered by Capital Market - Live News

Net profit of Aarti Pharmalabs declined 48.88% to Rs 27.92 crore in the quarter ended September 2025 as against Rs 54.62 crore during the previous quarter ended September 2024. Sales declined 8.67% to Rs 418.33 crore in the quarter ended September 2025 as against Rs 458.03 crore during the previous quarter ended September 2024. ParticularsQuarter EndedSep. 2025Sep. 2024% Var. Sales418.33458.03 -9 OPM %17.7120.45 - PBDT63.4692.65 -32 PBT38.6971.77 -46 NP27.9254.62 -49 Powered by Capital Market - Live News

Aarti Pharmalabs will hold a meeting of the Board of Directors of the Company on 9 November 2025.Powered by Capital Market - Live News